152 related articles for article (PubMed ID: 29630065)
1. Erratum: Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum].
Cancer Manag Res; 2018; 10():613. PubMed ID: 29630065
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum.
Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
[TBL] [Abstract][Full Text] [Related]
3. Erratum: Burden of uterine fibroids in Italy: epidemiology, treatment outcomes, and consumption of health care resources in more than 5,000 women [Corrigendum].
Clinicoecon Outcomes Res; 2017; 9():653. PubMed ID: 29081668
[TBL] [Abstract][Full Text] [Related]
4. Erratum: Humanistic and economic burden of fibromyalgia in Japan [Corrigendum].
J Pain Res; 2016; 9():1161. PubMed ID: 27980435
[TBL] [Abstract][Full Text] [Related]
5. Erratum: Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum].
Int J Womens Health; 2015; 7():403. PubMed ID: 25960676
[TBL] [Abstract][Full Text] [Related]
6. Erratum: Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum].
Ther Clin Risk Manag; 2014; 10():913. PubMed ID: 25412931
[TBL] [Abstract][Full Text] [Related]
7. Erratum: Burden of comorbidities among Japanese patients with atrial fibrillation: a case study of dyspepsia [Corrigendum].
Clin Exp Gastroenterol; 2013; 6():193. PubMed ID: 24098088
[TBL] [Abstract][Full Text] [Related]
8. Erratum: Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives [Corrigendum].
J Blood Med; 2016; 7():233. PubMed ID: 27799836
[TBL] [Abstract][Full Text] [Related]
9. Erratum: How does cognitive dissonance influence the sunk cost effect? [Corrigendum].
Psychol Res Behav Manag; 2018; 11():79. PubMed ID: 29664477
[TBL] [Abstract][Full Text] [Related]
10. Erratum: Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum].
Infect Drug Resist; 2016; 9():43-5. PubMed ID: 27099523
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Cost-effectiveness of minimally invasive sacroiliac joint fusion [Corrigendum].
Clinicoecon Outcomes Res; 2016; 8():305. PubMed ID: 27445500
[TBL] [Abstract][Full Text] [Related]
12. Erratum: Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum].
Clinicoecon Outcomes Res; 2017; 9():231. PubMed ID: 28458569
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Cost analysis of pulmonary lobectomy procedure: comparison of stapler versus precision dissection and sealant [Corrigendum].
Clinicoecon Outcomes Res; 2018; 10():155. PubMed ID: 29559803
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece [Corrigendum].
Clinicoecon Outcomes Res; 2015; 7():161. PubMed ID: 25834459
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum.
Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM
J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Profile of eliglustat tartrate in the management of Gaucher disease [Corrigendum].
Ther Clin Risk Manag; 2016; 12():1083. PubMed ID: 27462161
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Amino acid management of Parkinson's disease: a case study [Corrigendum].
Int J Gen Med; 2016; 9():205. PubMed ID: 27354822
[TBL] [Abstract][Full Text] [Related]
18. Erratum: Russian guidelines for the management of COPD: algorithm of pharmacologic treatment [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2019; 14():243. PubMed ID: 30718949
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum].
Clinicoecon Outcomes Res; 2017; 9():75. PubMed ID: 28174493
[TBL] [Abstract][Full Text] [Related]
20. Erratum: A game changing LATITUDE: Role of abiraterone plus prednisolone in metastatic hormonesensitive prostate cancer.
Indian J Urol; 2019; 35(2):175. PubMed ID: 31000930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
